MedPath

CEFAZOLIN

Cefazolin for Injection, USP

Approved
Approval ID

5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 6, 2023

Manufacturers
FDA

Henry Schein, Inc.

DUNS: 012430880

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

cefazolin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0404-9833
Application NumberANDA203661
Product Classification
M
Marketing Category
C73584
G
Generic Name
cefazolin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 9, 2022
FDA Product Classification

INGREDIENTS (1)

CEFAZOLIN SODIUMActive
Quantity: 1 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFAZOLIN - FDA Drug Approval Details